Delphinus Medical Technologies, Inc., innovator and developer of SoftVue™, a whole breast ultrasound system that incorporates the first-ever ring transducer design, has named Mark J. Forchette president and chief executive officer. Forchette is an accomplished medtech executive with demonstrated success transforming industries and driving breakthrough technologies to market leadership. Prior to joining Delphinus, Forchette was president and chief executive officer of OptiMedica Corporation, an ophthalmic medical device company that dramatically changed the standard of care in retina, glaucoma and cataract. He led the start-up venture through development and growth, successfully completed multiple rounds of financing, and oversaw the company’s acquisition by Abbott Laboratories in 2013.
